Gimv launches life sciences investment platform
Listed investor Gimv is carving out its life sciences portfolio into a new platform that will give it the firepower to deploy bigger tickets and increase the size of its portfolio, the firm tells Unquote.
More on GPs
Great Hill opens London office to expand activity in Europe
Managing director Drew Loucks will head Boston-based PE firm’s new arm
The Bolt-Ons Digest – 20 March 2023
Unquote’s selection of the latest add-ons with Cinven's ETC, PAI's Apleona, TA Associate's Fairstone, and more
GP Profile: Inspirit anticipates carve-outs uptick with fundraising on the horizon by year-end
Complex carve-outs specialist could raise around GBP 75m for its second fund with debut vehicle around 70% deployed
Beyond Impact aims for EUR 100m close for alternative protein fund
Article 9 fund held EUR 25m first close in early 2022; targets stakes in non-animal proteins and ingredients
Latest News
Great Hill opens London office to expand activity in Europe
Managing director Drew Loucks will head Boston-based PE firm’s new arm
The Bolt-Ons Digest – 20 March 2023
Unquote’s selection of the latest add-ons with Cinven's ETC, PAI's Apleona, TA Associate's Fairstone, and more
Lenders sway fate of auctions in volatile LBO market
Vendors increasingly sounding out lenders before bidders to navigate uncertain M&A landscape
Keyhaven eyes Q4 2023 fund launch amidst lower mid-market GP-leds boom
Secondaries firm looks ahead to fourth fund; sweet spot of EUR 50m-100m for deals but can go up to EUR 500m